Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-01-06 @ 7:09 PM
Study NCT ID:
NCT07009860
Status:
RECRUITING
Last Update Posted:
2025-07-09
First Post:
2025-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Sponsor:
Altimmune, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-16
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-05
First Submit QC Date:
None
Study First Post Date:
2025-06-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-08
Last Update Post Date:
2025-07-09
Last Update Post Date Type:
ACTUAL